Back to Journals » Journal of Multidisciplinary Healthcare » Volume 13

A Response to: Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire [Letter]

Authors Priastana IKA 

Received 24 July 2020

Accepted for publication 27 July 2020

Published 11 August 2020 Volume 2020:13 Pages 785—786

DOI https://doi.org/10.2147/JMDH.S273725

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser



I Ketut Andika Priastana

Universitas Triatma Mulya, Badung, Bali, Indonesia

Correspondence: I Ketut Andika Priastana
Universitas Triatma Mulya, Badung, Bali, Indonesia
Tel +6283114213804
Email [email protected]

Dear editor
I have read the study of Mirmosayyeb et al entitled “Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire” with great interest. In this paper, the authors reported their study on comparing psychological difficulties in patients with migraine and those with epilepsy by using the PARADISE-24 questionnaire. 1

 

View the original paper by Mirmosayyeb and colleagues

 

Dear editor

I have read the study of Mirmosayyeb et al entitled “Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire” with great interest. In this paper, the authors reported their study on comparing psychological difficulties in patients with migraine and those with epilepsy by using the PARADISE-24 questionnaire.1

This research is very useful in the assessment of psychological difficulties in patients with migraine and epilepsy. I found a few things that need to be written by the author. Firstly, the authors mention that they used the Independent sample t-test and Fisher exact test were used for comparison between quantitative and qualitative variables. However, no results were found from the test. If indeed the test has been carried out, it is necessary to be included in the results section. Comparison with the test will be better than just using the mean ± SD comparison.

In selecting the number of respondents, the authors revealed that the data were gathered from 240 migraineurs and 210 patients with epilepsy. This difference in the number of respondents will certainly lead to gaps in the results of the study. Authors need to explain what is the impact of the different numbers of respondents in each group.

The authors chose migraine and epilepsy as variables to compare. In a previous study in the development of the PARADISE-24 Questionnaire, Cieza et al tested several variables including dementia, stroke, multiple sclerosis (MS), epilepsy, migraine, Parkinson′s Disease (PD), depression, schizophrenia or substance dependency.2 The authors need to explain in more detail about the selection of these two variables and need to consider several other variables to be used in the study to be compared.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Mirmosayyeb O, Shaygannejad V, Ghajarzadeh M. Comparison of psychological difficulties in patients with migraine and epilepsy using PARADISE-24 questionnaire. J Multidiscip Healthc. 2020;13:609–613. doi:10.2147/JMDH.S260056

2. Cieza A, Sabariego C, Anczewska M, et al. PARADISE 24: a measure to assess the impact of brain disorders on people’s lives. Zheng D, editor. PLoS One. 2015;10(7):e0132410. doi:10.1371/journal.pone.0132410

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.